Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 1/20 | 0.42 |
| ▸ | RORC | P51449 | 2/20 | 0.39 |
| ▸ | NTRK1 | P04629 | 3/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.36 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.35 |
| ▸ | TRPC3 | Q13507 | 1/20 | 0.35 |
| ▸ | TRPC7 | Q9HCX4 | 1/20 | 0.35 |
| ▸ | F2R | P25116 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL458155 | 0.88 | PDE4B (0.43) | PDE4BRORCTP53LMNAGRIN2B | |
| SCHEMBL14730220 | 0.88 | TP53 (0.45) | PDE4BRORCNTRK1TP53LMNA | |
| SCHEMBL14722527 | 0.87 | PDE4B (0.41) | PDE4BRORCNTRK1TP53LMNA | |
| SCHEMBL12064782 | 0.86 | PDE4B (0.42) | PDE4BRORCNTRK1TP53LMNA | |
| SCHEMBL459391 | 0.81 | PDE4B (0.42) | PDE4BRORCGRIN2B | |
| SCHEMBL14722228 | 0.81 | PDE4B (0.42) | PDE4BRORC | |
| SCHEMBL458181 | 0.80 | PDE4B (0.43) | PDE4BRORCGRIN2B | |
| SCHEMBL457195 | 0.79 | PDE4B (0.42) | PDE4BRORCGRIN2B | |
| SCHEMBL470735 | 0.78 | NTRK1 (0.42) | RORCNTRK1NPY5RF2R | |
| SCHEMBL12064593 | 0.77 | PDE4B (0.42) | PDE4BRORCGRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011147951-A1 | CYCLOAMINO DERIVATIVES AS GPR119 ANTAGONISTS | PROSIDION LIMITED (GB) | 2011-12-01 | — | — | WO | disclosed |